Dr Christian Smith 🧬🔬

Love is in the air ❤️☁️

Congratulations Dr. Levine on becoming a double doctor! Today he successfully defended his PhD! Well done and wishing you much success in the future 🎉🔬

🎉 Congratulations Dr. Bennett, Dr. Levine, Dr. Nobre and the contributing authors on our @NatureCancer publication “A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis” rdcu.be/em0BS

New in Nature Cancer: CANON co-lead Dr. Julie Bennett and team show that 31% of AYA gliomas carry pediatric-type alterations. Findings highlight the need for age-specific approaches to diagnosis and treatment. nature.com/articles/s4301…

Groundbreaking study from ⁦@BTRCSickKids⁩ lab of ⁦@BrainSurgn1989⁩⁩ that investigates injury response/inflammation in glioblastoma (brain cancer that claimed lives of Gord Downey, John McCain and too many others) formation. nature.com/articles/s4158…

An exciting day, 19 years in the making.

It's International Brain Tumour Awareness Week. There are more than 150 types of brain tumours. PRIMARY, METASTATIC, BENIGN, MALIGNANT: 🧠 Primary brain tumours originate in the brain. 🧠 Metastatic” tumours originate elsewhere in the body and spread to the brain. 🧠 Primary brain tumours can be benign (non-cancerous) or malignant (cancerous). 🧠 Malignant brain tumours account for 38% of all primary brain tumours. Each type has its own symptoms, life-altering impact, varying options for treatment, and outcomes. A malignant brain tumour prognosis remains grim. These tumours tend to grow quickly, invade normal (healthy) brain, and spread to other parts of the brain. The overall 5-year relative survival for malignant brain tumours is approximately 5%. For brain cancers in children, adolescents, young adults, and adults, there are very few clinical trials, experimental therapies are exceedingly difficult to access, and options for effective therapies require decades to progress. Increased investment in research, medical therapies, clinical trials, and neuro-surgical technologies will continue to lead to better outcomes for patients and give clinicians more options to help their patients. Brain Cancer Canada invests 100% of its net proceeds towards brain cancer research and neuro-surgical technologies. Here are a couple of examples of how BCC’S investments have advanced medical care for brain cancer patients: 1) A next-generation genomic sequencer acquired by @StMichaelsFdn, the first of its kind in Canada, benefits patients with all tumour types (benign and malignant). Genomic sequencers help reveal details about the biology of a disease, how it originates and progresses, which then leads to understanding how medical therapies might be able to intervene. @SunnyD_UT 2) Preclinical studies at @SickKidsNews for Diffuse Intrinsic Pontine Glioma (DIPG), a pediatric brain cancer, which was translated into the “first in human” clinical trial for children with this fatal brainstem tumour. @JamesRutka Join us this week, as we work to raise awareness about the urgent need for brain cancer research! #braintumourawarenessweek #MalignantBrainTumours

Dr. Cynthia Hawkins has been elected as a fellow of the Canadian Academy of Health Sciences (CAHS)! Congratulations Dr. Hawkins on receiving one of Canada’s highest academic honours in the health sciences community. 🎉

Congratulations to the @ZadehLab and @gelarehzadeh for this outstanding study just published in @NatureMedicine

#UofT Professor Emeritus Geoffrey Hinton has won the 2024 Nobel Prize for Physics. Hinton shares the prize with John J. Hopfield “for foundational discoveries and inventions that enable machine learning with artificial neural networks.” #NobelPrize uoft.me/aXz

Excited to speak at the 12th Annual Traynor Lectureship in Neuro-Oncology on Oct 23 at The Hospital for Sick Children, discussing oncolytic immune-activation for glioblastoma. Honored to celebrate 25 years of the BTRC! #NeuroOncology #GlioblastomaResearch #BTRC25 @MGBneurosurgery

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Launch Day tomorrow! Day 7 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling Set Shuter, Jessica Robinson, and @drcasmith with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

Almost there! Day 6 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling @AdellePurdham, Nicola Perry, and Jessica Mannion with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

Day 5 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling @wandawriting, Kimberly Fraser, and Pamela Oakley with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

Day 4 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling @MegzyCole, @AlisonKarlene, and ME Burns with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

Day 3 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling @afinemedley, Linda Browne, and @NellwynLampert with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

Day 2 of the 7-day countdown to the release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. Today, I am profiling @neilsenglenn @StaceyMayFowles and @AnnaMorganLP with summaries of their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio #BadArtistBook #Creativity #PreOrderNow

@countrygillian @NellwynLampert

We are excited to announce the upcoming release of Bad Artist: Creating in a Productivity-Obsessed World on Oct 1st! 📚✨ This collection of essays from 21 diverse writers offers a powerful antidote to the toxic productivity culture, celebrating creativity for its own sake. In a 7-day countdown, I’ll be profiling three contributors each day and summarizing their essays. Pre-order now and join the movement to redefine what it means to be an artist in today’s world. Link in bio! #BadArtistBook #Creativity #PreOrderNow